News & Media

Take a look inside our world

Feature stories

Generic Medicines and R&D: How Teva Produces the World’s Biggest Medicine Cabinet

Generic Medicines and R&D: How Teva Produces the World’s Biggest Medicine Cabinet

Why Diversity in Clinical Trials is So Important

Why Diversity in Clinical Trials is So Important

Meet the Expert: Barak Zohar

Meet the Expert: Barak Zohar

Meet the Expert: Woodrow “Woody” Dantzler III

Meet the Expert: Woodrow “Woody” Dantzler III

The Power of Our People: Inclusion and Diversity at Teva

The Power of Our People: Inclusion and Diversity at Teva

7 Things You Need To Know About Multiple Chronic Conditions (MCC)

7 Things You Need To Know About Multiple Chronic Conditions (MCC)

Meet the Expert: Ivana Šoljić Jerbić

Meet the Expert: Ivana Šoljić Jerbić

Meet the Expert: Sebastian Horn

Meet the Expert: Sebastian Horn

Press Releases

Teva Announces Early Tender Results of its Debt Tender Offer, Increase of the Maximum Tender Amount ...

Teva Announces Early Tender Results of its Debt Tender Offer, Increase of the Maximum Tender Amount and E

Teva Becomes First Pharmaceutical Company to Execute Sustainability-linked Bond Tied to both Climate...

Teva Becomes First Pharmaceutical Company to Execute Sustainability-linked Bond Tied to both Climate and

Teva Announces Successful Upsize of Sustainability-Linked Senior Notes Offering and Pricing of $5,00...

Teva Announces Successful Upsize of Sustainability-Linked Senior Notes Offering and Pricing of $5,000,000

California Judge Rules That Teva Did Not Cause a Public Nuisance or Make False or Misleading Stateme...

California Judge Rules That Teva Did Not Cause a Public Nuisance or Make False or Misleading Statements A

New Phase 3 Data Presented at Psych Congress 2021 Showed TV-46000/mdc-IRM Significantly Prolonged Ti...

New Phase 3 Data Presented at Psych Congress 2021 Showed TV-46000/mdc-IRM Significantly Prolonged Time to

Teva Announces Launch of $4,000,000,000 Offering of Sustainability-linked Senior Notes

Teva Announces Launch of $4,000,000,000 Offering of Sustainability-linked Senior Notes

Teva Announces $3,500,000,000 Debt Tender Offers for Notes Due 2022-2024

Teva Announces $3,500,000,000 Debt Tender Offers for Notes Due 2022-2024

Teva Reports Third Quarter 2021 Financial Results

Teva Reports Third Quarter 2021 Financial Results

Teva and MODAG Announce Licensing Collaboration for Neurodegenerative Disease Drug Candidate

Teva and MODAG Announce Licensing Collaboration for Neurodegenerative Disease Drug Candidate

Teva to Present New Data from Growing Mental Health Portfolio at Psych Congress 2021

Teva to Present New Data from Growing Mental Health Portfolio at Psych Congress 2021

Connect with us on social media


Follow us on Facebook

Go to facebook.com

Follow us on Linkedin

Go to linkedin.com

Teva Social Media Guidelines

Connect with us

Contacts for Media Inquiries

Kelley Dougherty

Corporate Communications North America

+1-973-658-0237
Kelley.Dougherty@tevapharm.com

Yonatan Beker

Corporate Communications Israel

+972-3-9187869
Yonatan.Beker@tevapharm.com

Cedric Jungpeter

Corporate Communications International Markets

+972-54-8887729
Cedric.Jungpeter@teva.co.il

Leslie McGibbon

Corporate Communications Europe

Leslie.Mcgibbon@Tevaeu.com